Application of the 2022 ACR/EULAR criteria for microscopic polyangiitis to patients with previously diagnosed microscopic polyangiitis

医学 显微镜下多血管炎 肉芽肿伴多发性血管炎 内科学 痹症科 一致性 抗中性粒细胞胞浆抗体 蛋白酶3 血管炎 胃肠病学 病理
作者
Jung Yoon Pyo,Sung Soo Ahn,Jason Jungsik Song,Yong-Beom Park,Sang-Won Lee
出处
期刊:Clinical and Experimental Rheumatology [Springer Vienna]
标识
DOI:10.55563/clinexprheumatol/vmrk76
摘要

This study applied the 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology (the 2022 ACR/EULAR) criteria for microscopic polyangiitis (MPA) to patients with previously diagnosed MPA as per the 2007 European Medicines Agency algorithm (the 2007 EMA algorithm) and the 2012 revised International Chapel Hill Consensus Conference nomenclature of vasculitides (the 2012 CHCC definitions) The concordance rate between the new and old criteria was investigated.This study included 117 patients with MPA, and the new criteria were applied to these patients. MPA could be classified when the total score is ≥5.The median age was 64.0 years. The concordance rate between the new and old criteria reached 96.6%. Four patients with previously diagnosed MPA were unclassified. Of these, three patients without myeloperoxidase (MPO)-antineutrophil cytoplasmic antibody (ANCA) (or perinuclear [P]-ANCA) were not reclassified as having MPA according to the new criteria, despite histopathological findings that were suggestive of MPA based on both the 2007 EMA algorithm and the 2012 CHCC definitions. Conversely, three of four patients with both MPO-ANCA (or P-ANCA) and proteinase 3 (PR3)- ANCA (or cytoplasmic [C]-ANCA) were reclassified as having both MPA and granulomatosis with polyangiitis (GPA) simultaneously according to the 2022 ACR/EULAR criteria for MPA and GPA.In the new criteria, excessively high score was assigned to MPO-ANCA (or P-ANCA) and MPA-specific histopathological findings were not considered. Hence, the 2007 EMA algorithm and the 2012 CHCC definitions can be applied as additional criteria to complex cases.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhaoben关注了科研通微信公众号
刚刚
彭于晏的应助被淡淡听枫采纳,获得30
刚刚
刚刚
良人完成签到,获得积分10
1秒前
馒头发布了新的文献求助10
1秒前
1秒前
科研通AI2S的应助被八戒的梦想采纳,获得10
1秒前
2秒前
2秒前
可爱的函函的应助被大方元风采纳,获得10
2秒前
yzjyzj完成签到,获得积分10
3秒前
今后的应助被红莲墨生采纳,获得10
3秒前
热塑性哈士奇完成签到,获得积分10
3秒前
科研通AI6.4的应助被nwy采纳,获得10
4秒前
十二完成签到,获得积分0
5秒前
youkang完成签到,获得积分10
5秒前
芋泥啵啵发布了新的文献求助10
5秒前
jiacooo发布了新的文献求助10
5秒前
勿忘发布了新的文献求助10
6秒前
星辰大海的应助被cc采纳,获得20
6秒前
Arina发布了新的文献求助10
6秒前
领导范儿的应助被壮观雁易采纳,获得10
6秒前
7秒前
华仔的应助被科研通管家采纳,获得10
7秒前
香蕉觅云的应助被科研通管家采纳,获得10
7秒前
大模型的应助被科研通管家采纳,获得10
7秒前
7秒前
情怀的应助被科研通管家采纳,获得10
7秒前
充电宝的应助被科研通管家采纳,获得10
7秒前
爆米花的应助被科研通管家采纳,获得10
7秒前
搜集达人的应助被科研通管家采纳,获得10
8秒前
酷波er的应助被逢考必过采纳,获得10
8秒前
今后的应助被科研通管家采纳,获得30
8秒前
bkagyin的应助被科研通管家采纳,获得10
8秒前
无花果的应助被科研通管家采纳,获得10
8秒前
无花果的应助被科研通管家采纳,获得10
8秒前
Lucas的应助被Lu采纳,获得10
8秒前
我是老大的应助被科研通管家采纳,获得10
8秒前
无情愫的应助被科研通管家采纳,获得10
8秒前
大个的应助被科研通管家采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184267
求助须知:如何正确求助?哪些是违规求助? 9573323
关于积分的说明 21830790
捐赠科研通 7781314
什么是DOI,文献DOI怎么找? 3434307
关于科研通互助平台的介绍 2558389
邀请新用户注册赠送积分活动 2480817